seed
Stage
1
Investors
About
Innovodigm develops a proprietary microneedle-based platform for painless, thermostable, transdermal delivery of vaccines and biologics, improving accessibility and reducing vaccine wastage in remote areas.
Explore Innovodigm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.